Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,244 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04.
Ahn JS, Ahn YC, Kim JH, Lee CG, Cho EK, Lee KC, Chen M, Kim DW, Kim HK, Min YJ, Kang JH, Choi JH, Kim SW, Zhu G, Wu YL, Kim SR, Lee KH, Song HS, Choi YL, Sun JM, Jung SH, Ahn MJ, Park K. Ahn JS, et al. Among authors: lee cg, lee kc, lee kh. J Clin Oncol. 2015 Aug 20;33(24):2660-6. doi: 10.1200/JCO.2014.60.0130. Epub 2015 Jul 6. J Clin Oncol. 2015. PMID: 26150444 Clinical Trial.
Nail toxicity after treatment with docetaxel: a prospective analysis in patients with advanced non-small cell lung cancer.
Hong J, Park SH, Choi SJ, Lee SH, Lee KC, Lee JI, Kyung SY, An CH, Lee SP, Park JW, Jeong SH, Nam E, Bang SM, Cho EK, Shin DB, Lee JH. Hong J, et al. Among authors: lee sh, lee kc, lee sp, lee ji, lee jh. Jpn J Clin Oncol. 2007 Jun;37(6):424-8. doi: 10.1093/jjco/hym042. Epub 2007 Jun 21. Jpn J Clin Oncol. 2007. PMID: 17584826 Clinical Trial.
A phase II study of weekly paclitaxel, cisplatin and concurrent radiation therapy for locally-advanced unresectable non-small cell lung cancer: early closure due to lack of efficacy.
Park SH, Kim MK, Kyung SY, Lim YH, An CH, Park JW, Jeong SH, Lee JW, Lee KC, Cho EK, Bang SM, Shin DB, Lee JH. Park SH, et al. Among authors: lee kc, lee jw, lee jh. Cancer Res Treat. 2004 Oct;36(5):293-7. doi: 10.4143/crt.2004.36.5.293. Epub 2004 Oct 31. Cancer Res Treat. 2004. PMID: 20368818 Free PMC article.
Additional rituximab-CHOP (R-CHOP) versus involved-field radiotherapy after a brief course of R-CHOP in limited, non-bulky diffuse large B-cell lymphoma: a retrospective analysis.
Hong J, Kim AJ, Park JS, Lee SH, Lee KC, Park J, Sym SJ, Cho EK, Shin DB, Lee JH. Hong J, et al. Among authors: lee sh, lee kc, lee jh. Korean J Hematol. 2010 Dec;45(4):253-9. doi: 10.5045/kjh.2010.45.4.253. Epub 2010 Dec 31. Korean J Hematol. 2010. PMID: 21253427 Free PMC article.
A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: results of a Korean Radiation Oncology Group (KROG-0201) study.
Moon SH, Cho KH, Chung EJ, Lee CG, Lee KC, Chai GY, Kang KM, Lee JY, Chung WK, Park WY, Kim JH. Moon SH, et al. Among authors: lee cg, lee kc, lee jy. Radiother Oncol. 2014 Jan;110(1):98-103. doi: 10.1016/j.radonc.2013.09.016. Epub 2013 Oct 22. Radiother Oncol. 2014. PMID: 24161568 Clinical Trial.
Dummy Run of Quality Assurance Program before Prospective Study of Hippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases from Non-small Cell Lung Cancer: Korean Radiation Oncology Group (KROG) 17-06 Study.
Chung E, Noh JM, Lee KC, Kim JH, Chung WK, Suh YG, Lee JA, Seol KH, Wu HG, Kim YS, Noh OK, Park JW, Lee DS, Lee J, Kim YS, Park WY, Kang MK, Jo S, Ahn YC. Chung E, et al. Among authors: lee ja, lee kc, lee j, lee ds. Cancer Res Treat. 2019 Jul;51(3):1001-1010. doi: 10.4143/crt.2018.415. Epub 2018 Oct 15. Cancer Res Treat. 2019. PMID: 30322229 Free PMC article.
2,244 results